A emerging therapeutic frontier represents hybrid chains. Such engineered molecules merge portions of multiple amino acid sources, enabling the creation of distinct pharmacological properties. This approach provides https://chimerapeptides042538.dm-blog.com/43599876/chimera-peptides-a-novel-therapeutic-frontier